Alexander R. Vaccaro, MD, PhD (Thomas Jefferson University), Rick C. Sasso, MD (Indiana Spine Group and Indiana University School of Medicine), Carlo Bellabarba, MD (University of Washington and Harborview Medical Center) and Christopher K. Kepler, MD, MBA (Thomas Jefferson University) discuss type II odontoid fractures.

Disclosures:

Bellabarba, Carlo: Nothing to Disclose  

Kepler, Christopher K.: Grants: NIH (I, Paid directly to institution/employer); Other Office: Clinical Spine Surgery (Nonfinancial); Research Support (Staff and/or materials): CSRS (D, Paid directly to institution/employer), RTI (C, Paid directly to institution/employer); Royalties: Inion (None).

Sasso, Rick C.: Board of Directors: Cervical Spine Research Society (None); Consulting: NuVasive (C); Research Support (Staff and/or materials): Cerapedics (E, Paid directly to institution/employer), Medtronic (B, Paid directly to institution/employer), Smith and Nephew (D, Paid directly to institution/employer); Royalties: Medtronic (I).

Vaccaro, Alexander R.: Board of Directors: AO Spine (Knowledge Forum Director), Flagship Surgical (None),  Innovative Surgical Design (None), Parvizi Surgical Innovation (Nonfinancial), Prime Surgeons (Nonfinancial), Progressive Spinal Technologies (Nonfinancial), Spine Therapy Network Inc (Nonfinancial); Consulting: Atlas Spine (B), Depuy (None), Gerson Lehrman Group (None), Globus (C), Guidepoint Global (B), Innovative Surgical Design (None), Medtronics (B), Nuvasive (None), Orthobullets (None), Spine Wave (B), Stout Medical (None), Stryker Spine (F); Other: Clinical Spine Surgery (Editor in Chief); Royalties: Elsevier (B),  Globus (F), JayPee Books (A), Medtronic (E), Stryker Spine (F), Taylor Francis (A), Thieme (B); Stock Ownership (including options, warrants): Advanced Spinal Intellectual Properties (30%), Avaz Surgical (less than 1%), Bonovo Orthopaedics (less than 1%), Computational Biodynamics (less than 1%),  Cytonics (less than 1%), Dimension Orthotics LLC (less than 1%), Electrocore (D), Flagship Surgical (less than 1%), FlowPharma (less than 1%), Franklin Bioscience (less than 1%), Globus (111,098 shares), Innovative Surgical Design (less than 1%), Insight Therapeutics (less than 1%), Nuvasive (less than 1%),  Paradigm Spine (less than 1%), Parvizi Surgical Innovation (less than 1%), Prime Surgeons (less than 1%), Progressive Spinal Technology (less than 1%),  Replication Medica (less than 1%), Spine Medica (less than 1%), Spinology (less than 1%), Stout Medical (631 shares), Vertiflex (less than 1%).

Key: A: $100-$1,000; B: $1001-$10,000; C: $10,001-$25,000; D: $25,001-$50,000; E: $50,001-$100,000; F: $100,001- $500,000; G: $500,001-$1M; H: $1,000,001- $2.5M; I: $2.5M+